A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer (Q37258981)
Jump to navigation
Jump to search
scientific article published on 13 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer |
scientific article published on 13 June 2015 |
Statements
1 reference
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer (English)
1 reference
John Hainsworth
1 reference
Celestia S Higano
1 reference
Maha Hussain
1 reference
Dana Rathkopf
1 reference
Glenn Liu
1 reference
Andrew Armstrong
1 reference
Wm Kevin Kelly
1 reference
Anna Ferrari
1 reference
Adarsh Joshi
1 reference
Rebecca R Hozak
1 reference
Ling Yang
1 reference
Jonathan D Schwartz
1 reference
13 June 2015
1 reference
1 reference
1714-1724
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference